Adaptive stereotactic body radiation therapy

DEVICE2 trials

Sponsors

Washington University School of Medicine, University Health Network, Toronto

Conditions

Cancer of the PancreasGlottic CarcinomaPancreas AdenocarcinomaPancreas Cancer

Phase 2

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

Active, not recruitingNCT04331041

Washington University School of MedicinePancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma

Start: 2021-08-24End: 2027-04-21Updated: 2026-05-08

Volumetric Adaptive SBRT Versus Conventional Accelerated Radiation Therapy for Early-Stage Glottic Cancer

Not yet recruitingNCT07895745

University Health Network, TorontoGlottic Carcinoma

Start: 2027-01-01End: 2032-01-01Target: 150Updated: 2026-10-26

Related Papers

A phase II study of stereotactic body radiotherapy and focal adhesion kinase inhibitor in advanced pancreatic adenocarcinoma.

Journal of Clinical Oncology2026-01-10

Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade

Cancer Discovery2022-09-2794 citations

Abstract PO-112: Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade

Cancer Research2021-11-15